Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy

Overview of attention for article published in Intensive Care Medicine, August 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs: 1 blog
twitter: 62 X users

facebook: 4 Facebook pages
bluesky: 4 Bluesky users

Readers on

mendeley: 56 Mendeley

So far, Altmetric has seen 5 Bluesky posts from 4 Bluesky users, with an upper bound of 3,501 followers.

#VisualAbstract Meropenem and piperacillin/tazobactam dosing in critically ill patients on RRT depends on RRT intensity, duration, and urine output. Continuous infusions improve efficacy and safety. Dosing nomograms guide optimal therapy. zurl.co/GIsFB

Meropenem and piperacillin/tazobactam dosing in critically ill patients on RRT depends on RRT intensity, duration, and urine output. Continuous infusions improve efficacy and safety. Dosing nomograms guide optimal therapy. zurl.co/Gos9g

RP @absteward.bsky.social: 🆕🔥Prospective,multinational PK study by 🌟 Prof. Roberts Meropenem & pip/tazo optimised dosing regimens for critically ill patients receiving RRT Dosing nomograms developed to inform dosing for different RRT settings, urine ou…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 1 additional Bluesky posts.